Your session is about to expire
← Back to Search
Immunotherapy
Chemotherapy vs Biological Therapy for Pancreatic Cancer
Phase 2
Waitlist Available
Research Sponsored by Meyer Pharmaceuticals
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Hepatic: Bilirubin no greater than 3.0 mg/dL, SGOT or SGPT no greater than 3 times upper limit of normal
No symptomatic third space fluid collection (e.g., ascites, pleural effusion)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial is comparing the effectiveness of two different types of treatment for pancreatic cancer.
Who is the study for?
This trial is for adults with inoperable pancreatic cancer, who have a life expectancy of at least 3 months. They should have normal kidney and liver function, no recent heart attacks or congestive heart failure, not be HIV positive or pregnant, and willing to use contraception. Those with prior chemotherapy, radiotherapy or biological therapy treatments are excluded.Check my eligibility
What is being tested?
The study compares the effectiveness of gemcitabine (a chemotherapy drug) versus biological therapy (treatments that use the body's immune system to fight cancer). Patients will be randomly assigned to receive either treatment to determine which is more effective for pancreatic cancer that cannot be removed surgically.See study design
What are the potential side effects?
Gemcitabine may cause flu-like symptoms, fatigue, rash and mild liver enzyme elevations. Biological therapies can lead to immune-related side effects such as fever or inflammation in different parts of the body.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My liver function tests are within the required range.
Select...
I do not have fluid buildup causing symptoms like swelling or pain.
Select...
My creatinine level is 1.5 mg/dL or lower.
Select...
I am 18 years old or older.
Select...
I am mostly able to care for myself and carry out daily activities.
Select...
I haven't had a heart attack in the last 3 months and don't have heart failure.
Select...
My pancreatic cancer is at stage II, III, or IV and cannot be surgically removed.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Find a Location
Who is running the clinical trial?
Meyer PharmaceuticalsLead Sponsor
Michael F. O'NeillStudy ChairMeyer Pharmaceuticals
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My liver function tests are within the required range.It has been over 30 days since my last surgery, but I've had surgery to relieve symptoms.I do not have fluid buildup causing symptoms like swelling or pain.I have never undergone chemotherapy.I have not had any prior radiotherapy.I have not had any biologic therapy treatments.My creatinine level is 1.5 mg/dL or lower.I am 18 years old or older.I am mostly able to care for myself and carry out daily activities.I haven't had a heart attack in the last 3 months and don't have heart failure.I am not currently taking any systemic steroids.It's been over 30 days since I last participated in a clinical trial.My pancreatic cancer is at stage II, III, or IV and cannot be surgically removed.
Research Study Groups:
This trial has the following groups:Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What potential risks may be associated with this therapeutic approach?
"With no existing clinical data showing efficacy, this treatment has been rated a 2 on our safety scale, as it is currently in Phase 2 of the trial process."
Answered by AI
Are there still vacancies available for participants in this clinical experiment?
"This medical trial, initially posted on December 1st 1998, is no longer accepting patients. Nonetheless, 697 other clinical trials are actively recruiting participants as of this moment."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger